741 results on '"Satoh, Fumitoshi"'
Search Results
202. Time course and factors predicting arterial stiffness reversal in patients with aldosterone-producing adenoma after adrenalectomy: prospective study of 102 patients
203. Intratumoral heterogeneity of steroidogenesis in aldosterone-producing adenoma revealed by intensive double- and triple-immunostaining for CYP11B2/B1 and CYP17
204. Clinical Management and Outcomes of Adrenal Hemorrhage Following Adrenal Vein Sampling in Primary Aldosteronism
205. Expression of CYP11B2 in Aldosterone-Producing Adrenocortical Adenoma: Regulatory Mechanisms and Clinical Significance
206. Calibration and evaluation of routine methods by serum certified reference material for aldosterone measurement in blood
207. Intra-adrenal Aldosterone Secretion: Segmental Adrenal Venous Sampling for Localization
208. Cellular and Genetic Causes of Idiopathic Hyperaldosteronism.
209. Computed Tomography and Adrenal Venous Sampling in the Diagnosis of Unilateral Primary Aldosteronism.
210. UNILATERALLY SELECTIVE ADRENAL VEIN SAMPLING FOR IDENTIFICATION OF SURGICALLY CURABLE PRIMARY ALDOSTERONISM.
211. NEW SCREENING CUTOFF VALUES FOR DETECTION OF ALDOSTERONOMA EXAMINED BY LC-MS/MS AND NEWLY DEVELOPED NON-COMPETITIVE CLEIA.
212. Liquid chromatography-tandem mass spectrometry analysis of human adrenal vein corticosteroids before and after ACTH stimulation
213. Is there a role for segmental adrenal venous sampling and adrenal sparing surgery in patients with primary aldosteronism?
214. Abstract MP10: Nobelty and Significance of the Rapid Measurement of Plasma Aldosterone Concentration and Active Renin Concentration
215. Aldosterone biosynthesis in the human adrenal cortex and associated disorders
216. Abstract 135: Activated Intrarenal Renin Angiotensin System Contributes to the Development of Chronic Kidney Disease in Primary Aldosteronism
217. Dynamic multidetector CT and non-contrast-enhanced MR for right adrenal vein imaging: comparison with catheter venography in adrenal venous sampling
218. Adrenocortical Carcinoma
219. Radiofrequency bipolar ablation therapy for primary aldosteronism patients: investigator-initiated exploratory clinical trial
220. Clinical significance of contralateral adrenal suppression during adrenal vein sampling in primary aldosteronism
221. Measurement of Peripheral Plasma 18-Oxocortisol Can Discriminate Unilateral Adenoma From Bilateral Diseases in Patients With Primary Aldosteronism
222. Relationship of Ocular Microcirculation, Measured by Laser Speckle Flowgraphy, and Silent Brain Infarction in Primary Aldosteronism
223. Rapid Screening of Primary Aldosteronism by a Novel Chemiluminescent Immunoassay.
224. Aldosterone-Producing Adenomas: Genotypes and Phenotypes.
225. Anatomical Variations of the Right Adrenal Vein: Concordance Between Multidetector Computed Tomography and Catheter Venography.
226. Voltage-gated calcium channels in the human adrenal and primary aldosteronism
227. Abstract 008: Novel Pathological Diagnosis Between Aldosterone Producing Adenoma And Idiopathic Hyperaldosteronism
228. Abstract 402: Surgical Treatment Of Aldosterone Producing Adenoma Could Change Renovascular Hemodynamics –Decrement Of Resistive Index Evaluated By Renal Doppler Sonography–
229. Different Expression of 11β-Hydroxylase and Aldosterone Synthase Between Aldosterone-Producing Microadenomas and Macroadenomas
230. Adrenal CYP11B1/2 expression in primary aldosteronism: Immunohistochemical analysis using novel monoclonal antibodies
231. The pathophysiology of aldosterone-producing adenomas associated with their tumor size: the smaller, the higher expression of CYP11B2
232. Response to Implementation of Rapid Cortisol During Adrenal Vein Sampling
233. Angiotensin II receptor blockers differentially affect CYP11B2 expression in human adrenal H295R cells
234. Aberrant gonadotropin-releasing hormone receptor (GnRHR) expression and its regulation of CYP11B2 expression and aldosterone production in adrenal aldosterone-producing adenoma (APA)
235. Development of monoclonal antibodies against human CYP11B1 and CYP11B2
236. PCP4: a regulator of aldosterone synthesis in human adrenocortical tissues
237. Identification of aldosterone production sites in primary aldosteronism
238. An Expert Consensus Statement on Use of Adrenal Vein Sampling for the Subtyping of Primary Aldosteronism
239. Glutamate receptors and the regulation of steroidogenesis in the human adrenal gland: The metabotropic pathway
240. 2. What Can We Do for the Proper Diagnosis and Treatment of Primary Aldosteronism?
241. Prognosis of primary aldosteronism in Japan: results from a nationwide epidemiological study
242. Activating Transcription Factor 3 (ATF3) in the Human Adrenal Cortex: Its Possible Involvement in Aldosterone Biosynthesis
243. Characterization of lipid-rich adrenal tumors by FDG PET/CT: Are they hormone-secreting or not?
244. Metallothionein-3 (MT-3) in the Human Adrenal Cortex and its Disorders
245. Increased expression of (pro)renin receptor in aldosterone-producing adenomas
246. Characterization and distribution of prolactin releasing peptide (PrRP) binding sites in the rat – evidence for a novel binding site subtype in cardiac and skeletal muscle
247. 原発性アルドステロン症診断のクリニカルパスとACTH負荷両側副腎静脈血同時採血法(原発性アルドステロン症におけるACTH負荷副腎静脈サンプリングの意義,第2回副腎静脈サンプリング研究会,プロシーディングス)
248. PS-C22-9: ANGIOTENSIN RECEPTOR-NEPRILYSIN INHIBITOR (ARNI) HAS MORE EFFECTS IN REDUCING ALDOSTERONE CONCENTRATIONS AND CARDIAC HYPERTROPHY IN WELL-CONTROLLED HYPERTENSIVE PATIENTS.
249. PS-C22-3: VALIDATION AND CLINICAL EVALUATION OF DIAGNOSTIC ABILITY OF NOVEL CHEMILUMINESCENT ENZYME IMMUNOASSAY OF PLASMA ALDOSTERONE CONCENTRATION.
250. PS-BPR01-6: A CASE SERIES OF UNILATERAL PRIMARY ALDOSTERONISM TREATED BY RADIOFREQUENCY ABLATION.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.